Lead Identification of Some Anti-Cancer Agents with Prominent Activity Against Non-small Cell Lung Cancer (NSCLC) and Structure-Based Design

被引：0
|
作者：
Muhammad Tukur Ibrahim
Adamu Uzairu
Gideon Adamu Shallangwa
Sani Uba
机构：
[1] Ahmadu Bello University,Department of Chemistry, Faculty of Physical Science
来源：
Chemistry Africa | 2020年 / 3卷
关键词：
Lead; NSCLC; Docking; Activity; Design;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1023 / 1044
页数：21
相关论文
共 50 条
  • [1] Lead Identification of Some Anti-Cancer Agents with Prominent Activity Against Non-small Cell Lung Cancer (NSCLC) and Structure-Based Design
    Ibrahim, Muhammad Tukur
    Uzairu, Adamu
    Shallangwa, Gideon Adamu
    Uba, Sani
    CHEMISTRY AFRICA-A JOURNAL OF THE TUNISIAN CHEMICAL SOCIETY, 2020, 3 (04): : 1023 - 1044
  • [2] Synergistic Anti-Cancer Activity of Melittin and Erlotinib in Non-Small Cell Lung Cancer
    Ibrahim, Hairulislam M.
    Alessa, Jihad
    Khalil, Hala Badr
    Bekhet, Gamal A.
    Khalifa, Ashraf
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (07)
  • [3] A novel anti-cancer role of β-apopicropodophyllin against non-small cell lung cancer cells
    Kim, Ju Yeon
    Cho, Jeong Hyun
    Choi, Jong-Ryoo
    Shin, Hyun-Jin
    Song, Jie-Young
    Hwang, Sang-Gu
    Um, Hong-Duck
    Do Yoo, Young
    Kim, Joon
    Park, Jong Kuk
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2018, 357 : 39 - 49
  • [4] Biomarker identification in non-small cell lung cancer (NSCLC) with activity-based proteomics
    Wiedl, Thomas
    Arni, Stephan
    Roschitzki, Bernd
    Grossmann, Jonas
    Soltermann, Alex
    Hillinger, Sven
    Aebersold, Rudolf
    Weder, Walter
    CANCER RESEARCH, 2011, 71
  • [5] ACTIVITY-BASED PROTEOMICS: BIOMARKER IDENTIFICATION IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Wiedl, Thomas
    Arni, Stephan
    Roschitzki, Bernd
    Grossmann, Jonas
    Soltermann, Alex
    Hillinger, Sven
    Aebersold, Ruedi
    Weder, Walter
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1038 - S1038
  • [6] Identification of Withaferin A as a Potential Candidate for Anti-Cancer Therapy in Non-Small Cell Lung Cancer
    Hsu, Jade H-M
    Chang, Peter M-H
    Cheng, Tai-Shan
    Kuo, Yu-Lun
    Wu, Alexander T-H
    Tran, Thu-Ha
    Yang, Yun-Hsuan
    Chen, Jing-Ming
    Tsai, Yu-Chen
    Chu, Yeh-Shiu
    Huang, Tse-Hung
    Huang, Chi-Ying F.
    Lai, Jin-Mei
    CANCERS, 2019, 11 (07)
  • [7] Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents against non-small cell lung cancer (NSCLC)
    Sei, S.
    Yang, Q.
    Mussio, J.
    Coffey, M.
    Parchment, R.
    Shoemaker, R.
    Tomaszewski, J.
    EJC SUPPLEMENTS, 2006, 4 (12): : 103 - 103
  • [8] Anti-cancer activity of fisetin in human non-small lung cancer cells
    Kang, Kyoung Ah
    Piao, Mei Jing
    Kim, Ki Cheon
    Zheng, Jian
    Yao, Cheng Wen
    Cha, Ji Won
    Hyun, Jin Won
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S45 - S45
  • [9] Anti-cancer effects of boron derivatives on non-small cell lung cancer
    Cebeci, Emre
    Yuksel, Buesra
    Sahin, Fikrettin
    JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, 2025, 88
  • [10] Development of pharmaceutically scalable inhaled anti-cancer nanotherapy - Repurposing amodiaquine for non-small cell lung cancer (NSCLC)
    Parvathaneni, Vineela
    Kulkarni, Nishant S.
    Chauhan, Gautam
    Shukla, Snehal K.
    Elbatanony, Rasha
    Patel, BrijeshKumar
    Kunda, Nitesh K.
    Muth, Aaron
    Gupta, Vivek
    MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2020, 115
12345